<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the present work, we developed a strategy for detecting residual <z:hpo ids='HP_0001909'>leukemia</z:hpo> in the marrow of children with standard risk-<z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (sr-ALL) at the end of therapy, based on the capacity of human leukemic cells for growing in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/<z:mp ids='MP_0002536'>SCID</z:mp> mice marrow microenvironment </plain></SENT>
<SENT sid="1" pm="."><plain>Mononuclear (MN) marrow cells from 62 patients were injected into sublethally irradiated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">NOD</z:e>/<z:mp ids='MP_0002536'>SCID</z:mp> mice and the engraftment kinetics and composition of the human grafts were determined periodically </plain></SENT>
<SENT sid="2" pm="."><plain>The presence of human leukemic cells with immunophenotypes and clonal DNA markers similar to those of the original leukemic clone was studied </plain></SENT>
</text></document>